More importantly, this is the first study showing that the integration of interim [18F]‐FDG‐PET/CT scan results after 2 chemotherapy cycles with presence of B‐symptoms and CD68+ cell counts at diagnosis, improves risk‐stratification of patients with HL. Here, CD68 is linked to Hodgkins lymphoma.